AstraZeneca Faces Sanctions In Seroquel MDL

Law360, New York (August 21, 2007, 12:00 AM EDT) -- The Florida court overseeing multidistrict products liability litigation over AstraZeneca LP's anti-psychotic drug Seroquel has ruled that the pharmaceutical company engaged in sanctionable conduct, granting in part a motion that accused the drug company of failing to comply with discovery obligations.

U.S. Magistrate Judge David A. Baker on Tuesday signed off on a 28-page order, finding that sanctions against AstraZeneca were warranted, and that AstraZeneca had been “purposefully sluggish” in making effective production to the plaintiffs.

Because the court had insisted on a tight schedule, “this...
To view the full article, register now.